Literature DB >> 7324903

Nasal vasomotor oscillations in the cat associated with the respiratory rhythm.

R Eccles, R L Lee.   

Abstract

Asymmetrical nasal vasomotor oscillations mediated via the cervical sympathetic nerve have been observed in the spontaneously breathing cat. The vasomotor activity persists after abolition of spontaneous respiration with a neuromotor relaxant agent indicating that the vasomotor activity originates in the respiratory areas of the brain and is not due to any of the mechanical effects of respiration. The nasal vasomotor activity is abolished on hyperventilation indicating that it may be driven from a central respiratory oscillator. The vasomotor activity exhibits a reciprocal activity with oscillations in sympathetic activity alternating from one nasal passage to the other and this may be due to a direct relationship with a nasal cycle in the cat.

Mesh:

Year:  1981        PMID: 7324903     DOI: 10.3109/00016488109133272

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  5 in total

1.  The central reciprocal control of nasal vasomotor oscillations.

Authors:  O S Bamford; R Eccles
Journal:  Pflugers Arch       Date:  1982-08       Impact factor: 3.657

2.  An anatomical investigation of the nasal venous vascular bed in the dog.

Authors:  M A Lung; J C Wang
Journal:  J Anat       Date:  1989-10       Impact factor: 2.610

3.  Control of nasal vasculature and airflow resistance in the dog.

Authors:  M A Lung; R J Phipps; J C Wang; J G Widdicombe
Journal:  J Physiol       Date:  1984-04       Impact factor: 5.182

4.  Measuring and Characterizing the Human Nasal Cycle.

Authors:  Roni Kahana-Zweig; Maya Geva-Sagiv; Aharon Weissbrod; Lavi Secundo; Nachum Soroker; Noam Sobel
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

5.  Relationship Between Nasal Cycle, Nasal Symptoms and Nasal Cytology.

Authors:  Alfonso Luca Pendolino; Bruno Scarpa; Giancarlo Ottaviano
Journal:  Am J Rhinol Allergy       Date:  2019-06-20       Impact factor: 2.467

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.